Talk of the ACA Shifts to Repair
The talk about the Affordable Care Act (ACA) has shifted among Republicans and the White House. According to The Wall Street Journal, President Donald Trump’s administration is considering how to shore up the ACA’s marketplaces. CMS has proposed a rule to stabilize the individual insurance market, but details still aren’t public. Meanwhile, Republicans are discussing how to repair Barack Obama’s health law. The talk on the Hill has shifted away from swiftly repealing the ACA.
California Lawmaker Discusses Plans to Cover Illegal Immigrants
Shortly after Trump took office, California withdrew a request for permission to sell unsubsidized health coverage through Covered California to illegal immigrants. In a new Q&A with California Healthline, state Democrat Senator Ricardo Lara, who initially made the request, discussed the decision to withdraw the waiver and how California will move forward with efforts to expand health coverage to immigrants without papers. California is home to more than 2.5 million illegal immigrants.
Keeping Protections for Vulnerable Patients
In an opinion piece for STAT, Michael J. Stephen, MD, who works with patients who have cystic fibrosis, outlines the protections that the ACA has provided for people with crippling chronic conditions. Beyond the 2 most popular provisions of the law—coverage for preexisting conditions and coverage until age 26 on a parent’s policy—the ACA also provides protections for participating in clinical trials, which has proven key to developing new medicines.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More